QF
MRSN

QVT Financial’s Mersana Therapeutics MRSN Stock Holding History

QVT Financial’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,506
Closed -$18.5K – 64
2025
Q2 		$18.5K Hold
2,506
– – ﹤0.01% 46
2025
Q1 		$21.6K Hold
2,506
– – ﹤0.01% 40
2024
Q4 		$89.6K Hold
2,506
– – 0.01% 35
2024
Q3 		$118K Hold
2,506
– – 0.01% 35
2024
Q2 		$126K Hold
2,506
– – 0.01% 33
2024
Q1 		$283K Hold
2,506
– – 0.03% 35
2023
Q4 		$145K Hold
2,506
– – 0.01% 34
2023
Q3 		$79.6K Hold
2,506
– – ﹤0.01% 39
2023
Q2 		$206K Hold
2,506
– – 0.01% 43
2023
Q1 		$258K Hold
2,506
– – 0.02% 51
2022
Q4 		$367K Hold
2,506
– – 0.02% 48
2022
Q3 		$424K Hold
2,506
– – 0.03% 51
2022
Q2 		$289K Hold
2,506
– – 0.02% 60
2022
Q1 		$250K Hold
2,506
– – 0.01% 67
2021
Q4 		$390K Hold
2,506
– – 0.01% 58
2021
Q3 		$591K Hold
2,506
– – 0.05% 58
2021
Q2 		$851K Hold
2,506
– – 0.06% 51
2021
Q1 		$1.01M Buy
+2,506
New +$1.22M 0.07% 47

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return